Medicine and Dentistry
Breast Cancer
100%
Systemic Therapy
56%
Retrospective Study
37%
Clinical Trial
34%
Event Free Survival
31%
Diagnosis
31%
Breast Surgery
31%
Patient Care
31%
Male Breast
31%
Breast Carcinoma
31%
Biopsy Technique
31%
Arm
31%
Papule
31%
Simple Mastectomy
31%
Methadone
31%
Diseases
28%
Triple Negative Breast Cancer
16%
Transcription Factor GATA 3
15%
Post-Anesthesia Care Unit
15%
Male Breast Cancer
14%
Malignant Neoplasm
13%
Hazard Ratio
12%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
12%
Carcinoma
11%
Metastatic Breast Cancer
11%
Hormone Therapy
10%
Randomized Clinical Trial
10%
Mastectomy
10%
Postoperative Pain
10%
Neoplasm
9%
Cancer
7%
Salivary Gland
7%
Estrogen Receptor
7%
Androgen Receptor
7%
Metastatic Carcinoma
7%
Tumor Recurrence
6%
Breast Tumor
6%
Recurrent Disease
6%
Proportional Hazards Model
6%
Multivariate Analysis
6%
Axillary Surgery
6%
Lenabasum
6%
Cancer Therapy
5%
Population Research
5%
Analgesia
5%
Acute Pain Management
5%
Extubation
5%
Pharmacokinetic
5%
Antiemetic
5%
Morphine
5%
Keyphrases
Pathological Complete Response
54%
Neoadjuvant Systemic Therapy
49%
Nodal Involvement
31%
Breast Reconstruction
31%
Breast Cancer Patients
31%
Trichorhinophalangeal Syndrome
31%
Exceptional Responders
31%
Invasive Breast Cancer
31%
Vacuum-assisted Biopsy
31%
Response Predictors
31%
Male Breast Carcinoma
31%
Personal Learning
31%
Phase II Trial
31%
Methadone
31%
Single-center Retrospective Study
31%
Total Mastectomy
31%
Event-free Survival
22%
HER2-positive Breast Cancer
18%
Image-guided
18%
Triple-negative Breast Cancer
17%
GATA3
15%
Postoperative Opioids
15%
Postanesthesia Care Unit
15%
Breast
13%
Breast Carcinoma
11%
Carcinoma
11%
Mastectomy
10%
Short-acting Opioids
10%
Timing of Surgery
10%
Pain Intensity
10%
Opioid Analgesics
10%
Breast Cancer
9%
Metastatic Breast Cancer
9%
Improved Survival
9%
Hazard Ratio
9%
Ipsilateral Breast Tumor Recurrence
9%
Male Patients
7%
Androgen Receptor
7%
Specific Marker
7%
Metastatic Carcinoma
7%
Invasive Breast Carcinoma
7%
Salivary Gland
7%
Estrogen Receptor
7%
Gender Inclusion
7%
Pharmacological Properties
5%
Acute Postoperative Pain
5%
Cancer Causes
5%
Baseline Characteristics
5%
Cancer Mortality
5%
Propensity Score
5%